Published in Ann Surg on December 01, 1987
Synthesis of type I collagen in healing wounds in humans. Ann Surg (1991) 1.19
Markers of collagen synthesis and degradation are increased in serum in severe sepsis: a longitudinal study of 44 patients. Crit Care (2009) 1.04
Changes in collagen metabolites in serum after cemented hip and knee arthroplasty. Arch Orthop Trauma Surg (1993) 0.84
Collagen synthesis in intact skin is suppressed during wound healing. Ann Surg (1993) 0.75
Collagen synthesis activity in the aqueous humour of eyes with glaucoma surgery: a pilot study. Br J Ophthalmol (1996) 0.75
Some statistical methods useful in circulation research. Circ Res (1980) 11.88
Computer analysis of radioligand assay and radioimmunoassay data. Acta Endocrinol Suppl (Copenh) (1970) 2.36
Sequential appearance of fibronectin and collagen in experimental granulation tissue. Lab Invest (1980) 2.16
Current concepts in soft connective tissue wound healing. Br J Surg (1983) 1.23
Development of a new miniature method for the study of wound healing in human subjects. J Surg Res (1982) 1.19
Collagen types in early phases of wound healing in children. Acta Chir Scand (1978) 1.14
Analysis of extracellular matrix proteins in biological fluids. Methods Enzymol (1987) 1.04
A possible mechanism for the regulation of collagen fibril diameter in vivo. Coll Relat Res (1983) 1.00
Purification and characterization of the N-terminal propeptide of human type III procollagen. Biochem J (1985) 0.95
Heterogeneity of the antigens related to the aminoterminal propeptide of type III procollagen in human serum. Clin Chim Acta (1982) 0.93
Ultrastructural characteristics of cells in human wound collected by Cellstic device. J Surg Res (1983) 0.83
Cellstic: A device for wound healing studies in man. Description of the method. J Surg Res (1976) 0.83
Fibronectin in early phases of wound healing in children. Acta Chir Scand (1981) 0.82
Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen. Clin Chem (1990) 2.51
Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: a new serum marker of bone collagen degradation. Clin Chem (1993) 2.44
7-S collagen: characterization of an unusual basement membrane structure. Eur J Biochem (1980) 2.19
Five-year follow-up after radical surgery for colorectal cancer. Results of a prospective randomized trial. Arch Surg (1995) 2.17
Monitoring of veno-occlusive disease after bone marrow transplantation by serum aminopropeptide of type III procollagen. Lancet (1993) 2.09
Rapid equilibrium radioimmunoassay for the amino-terminal propeptide of human type III procollagen. Clin Chem (1988) 2.01
Immunohistochemical study of colorectal tumors for expression of a novel transmembrane carbonic anhydrase, MN/CA IX, with potential value as a marker of cell proliferation. Am J Pathol (1998) 1.99
Macromolecular structure of basement membrane collagens. FEBS Lett (1981) 1.96
Collagen metabolism and growth in prepubertal children with asthma treated with inhaled steroids. J Pediatr (1998) 1.94
Type V collagen as the target for type-3 fimbriae, enterobacterial adherence organelles. Mol Microbiol (1990) 1.94
Collagen scar formation after acute myocardial infarction: relationships to infarct size, left ventricular function, and coronary artery patency. Circulation (1997) 1.93
Effect of chronic renal failure on bone turnover and bone alkaline phosphatase isoforms. Kidney Int (2001) 1.88
The O75X adhesin of uropathogenic Escherichia coli is a type IV collagen-binding protein. Mol Microbiol (1989) 1.87
The type I collagen fragments ICTP and CTX reveal distinct enzymatic pathways of bone collagen degradation. J Bone Miner Res (2003) 1.68
Serum markers of type I collagen formation and degradation in metabolic bone disease: correlation with bone histomorphometry. J Bone Miner Res (1993) 1.57
Immunohistochemistry of carbonic anhydrase isozyme IX (MN/CA IX) in human gut reveals polarized expression in the epithelial cells with the highest proliferative capacity. J Histochem Cytochem (1998) 1.57
Markers of fibrogenesis and basement membrane formation in alcoholic liver disease. Relation to severity, presence of hepatitis, and alcohol intake. Gastroenterology (1990) 1.56
Structural diversity and domain composition of a unique collagenous fragment (intima collagen) obtained from human placenta. Biochem J (1983) 1.55
Is the development of adenoma and carcinoma in proximal colon related to apolipoprotein E phenotype? Gastroenterology (1996) 1.54
Aberrant type I and type III collagen gene expression in human breast cancer in vivo. J Pathol (1998) 1.53
Biosynthesis of collagen and its alterations in pathological states. Med Biol (1976) 1.42
Collagen metabolites in the prediction of response to GH therapy in short children. Eur J Endocrinol (1997) 1.40
Laminin. Methods Enzymol (1982) 1.37
Serum concentration of the cross-linked carboxyterminal telopeptide of type I collagen (ICTP) is a useful prognostic indicator in multiple myeloma. Br J Cancer (1992) 1.34
Assay of collagen-galactosyltransferase and collagen-glucosyltransferase activities and preliminary characterization of enzymic reactions with transferases from chick-embryo cartilage. Eur J Biochem (1975) 1.32
Atrial extracellular matrix remodelling in patients with atrial fibrillation. J Cell Mol Med (2008) 1.28
Analysing connective tissue metabolites in human serum. Biochemical, physiological and methodological aspects. J Hepatol (1995) 1.27
Activities of prolyl hydroxylase, lysyl hydroxylase, collagen galactosyltransferase and collagen glucosyltransferase in the liver of rats with hepatic injury. Biochem J (1974) 1.25
Type IV collagen and laminin-related antigens in human serum in alcoholic liver disease. Eur J Clin Invest (1985) 1.22
Immunoassay for intact amino-terminal propeptide of human type I procollagen. Clin Chem (1996) 1.22
Synthesis of type I collagen in healing wounds in humans. Ann Surg (1991) 1.19
Cellular differentiation and expression of matrix genes in type 1 neurofibromatosis. Lab Invest (1988) 1.19
Palliative operations for colorectal cancer. Dis Colon Rectum (1990) 1.15
Prolyl 3-hydroxylase: partial characterization of the enzyme from rat kidney cortex. Eur J Biochem (1977) 1.15
Polymorphisms at the apoB, apoA-I, and cholesteryl ester transfer protein gene loci in patients with gallbladder disease. J Lipid Res (1995) 1.14
Circulating C-terminal propeptide of type I procollagen is cleared mainly via the mannose receptor in liver endothelial cells. Biochem J (1990) 1.12
Immunochemical characterization of assay for carboxyterminal telopeptide of human type I collagen: loss of antigenicity by treatment with cathepsin K. Bone (2000) 1.12
Demonstration of Chlamydia pneumoniae in the walls of abdominal aortic aneurysms. J Vasc Surg (1997) 1.11
Isolation and characterization of pepsin fragments of laminin from human placental and renal basement membranes. Biochem J (1981) 1.10
Aminoterminal propeptide of type III procollagen in serum during wound healing in human beings. Surgery (1990) 1.08
Partial purification and characterization of chick-embryo prolyl 3-hydroxylase. Biochem J (1979) 1.08
Postpneumonectomy empyema in pulmonary carcinoma patients. Treatment with antibiotic irrigation and closed-chest drainage. J Thorac Cardiovasc Surg (1976) 1.07
A new method to measure type I and III collagen synthesis in human skin in vivo: demonstration of decreased collagen synthesis after topical glucocorticoid treatment. J Invest Dermatol (1992) 1.07
Assessment of bone remodeling using biochemical indicators of type I collagen synthesis and degradation: relation to calcium kinetics. Bone Miner (1994) 1.07
Type I collagen degradation product (ICTP) gives information about the nature of bone metastases and has prognostic value in prostate cancer. Br J Cancer (1995) 1.06
Transdermal oestrogen therapy protects postmenopausal liver transplant women from osteoporosis. A 2-year follow-up study. J Hepatol (2001) 1.06
Mesenteric infarction. Am J Surg (1977) 1.05
Treatment of symptomatic congenital hepatic cysts with single-session percutaneous drainage and ethanol sclerosis: technique and outcome. J Vasc Interv Radiol (1997) 1.05
Increased type I collagen degradation correlates with disease severity in rheumatoid arthritis. Ann Rheum Dis (1993) 1.05
Collagen biosynthesis enzymes in serum and hepatic tissue in liver disease. I. Prolyl hydroxylase. Eur J Clin Invest (1979) 1.05
Analysis of extracellular matrix proteins in biological fluids. Methods Enzymol (1987) 1.04
Immunohistochemical study of type I collagen and type I pN-collagen in benign and malignant ovarian neoplasms. Cancer (1995) 1.04
Pachydermoperiostosis: analysis of the connective tissue abnormality in one family. J Am Acad Dermatol (1994) 1.04
Hyperglycemic glucose concentrations up-regulate the expression of type VI collagen in vitro. Relevance to alterations of peripheral nerves in diabetes mellitus. Am J Pathol (1993) 1.04
Markers of type I collagen degradation and synthesis in the monitoring of treatment response in bone metastases from breast carcinoma. Br J Cancer (1996) 1.03
Collagen glucosyltransferase. Partial purification and characterization of the enzyme from whole chick embryos and chick-embryo cartilage. Eur J Biochem (1976) 1.03
Systemic glucocorticoid treatment decreases serum concentrations of carboxyterminal propeptide of type I procollagen and aminoterminal propeptide of type III procollagen. Br J Dermatol (1992) 1.03
Glucosylation of galactosylhydroxylysyl residues in collagen in vitro by collagen glucosyltransferase. Inhibition by triple-helical conformation of the substrate. Eur J Biochem (1975) 1.03
Diagnostic accuracy of ultrasonography and C reactive protein concentration in acute cholecystitis: a prospective clinical study. Eur J Surg (1992) 1.03
Elevated serum levels of type I collagen degradation marker ICTP and tissue inhibitor of metalloproteinase (TIMP) 1 are associated with poor prognosis in lung cancer. Clin Cancer Res (2001) 1.02
Systemic glucocorticoids decrease the synthesis of type I and type III collagen in human skin in vivo, whereas isotretinoin treatment has little effect. Br J Dermatol (1994) 1.02
Estrogen reduces the depth of resorption pits by disturbing the organic bone matrix degradation activity of mature osteoclasts. Endocrinology (2001) 1.02
Biochemical markers of bone metabolism. Ann Med (1993) 1.01
Apolipoprotein E phenotype, cholesterol and breast and prostate cancer. J Epidemiol Community Health (2000) 1.01
Increase in circulating basement membrane antigens in diabetic rats and effects of insulin treatment. Diabetologia (1982) 1.00
Increased turnover of collagen in abdominal aortic aneurysms, demonstrated by measuring the concentration of the aminoterminal propeptide of type III procollagen in peripheral and aortal blood samples. J Vasc Surg (1995) 0.99
Sensitive radioimmunoassays for 7 S collagen and laminin: application to serum and tissue studies of basement membranes. Anal Biochem (1981) 0.99
Concurrent p53 expression in bronchial dysplasias and squamous cell lung carcinomas. Am J Pathol (1993) 0.99
Separation of prolyl 3-hydroxylase and 4-hydroxylase activities and the 4-hydroxyproline requirement for synthesis of 3-hydroxyproline. Biochem Biophys Res Commun (1976) 0.99
Progressive ovarian carcinoma induces synthesis of type I and type III procollagens in the tumor tissue and peritoneal cavity. Cancer Res (1993) 0.98